Search

everythinglearnresearchcommunity

for

Search:↓

Scientists developed a new way to study mutations in a skin condition using blood cells, which may help diagnose and treat the disease.

Improper use of benzyl benzoate on a dog can cause severe skin reactions.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

The Greek DCQ is a reliable and valid tool for assessing dysmorphic concern.

A man with alopecia universalis regrew hair temporarily after a bone treatment.

Bicalutamide added no extra benefit over minoxidil alone for female-pattern hair loss.

A new method using NBD-CL can accurately and precisely measure finasteride in medicine, and could be used regularly for quality control in the industry.

The treatments stopped hair regrowth in mice.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Birt–Hogg–Dubé Syndrome requires genetic testing for accurate diagnosis due to its similarities with tuberous sclerosis.

The document listed medical job ads and guidelines for breast cancer screening.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

BAP1 mutations are rare in pediatric melanocytic tumors and may develop later in life.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

The document describes previously unreported unique skin changes in a rare genetic disorder called Hereditary mucoepithelial dysplasia.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Pediatric patients with dystrophic epidermolysis bullosa face more hospital admissions, procedures, and complications than others.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

A new, quick method accurately detects minoxidil in drugs and cosmetics.

A low-cost, 3D-printed light therapy device is safe and effective but needs more testing before use on people.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.